|Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study|
Y Li, M Li, M Wang, Y Zhou, J Chang, Y Xian, D Wang, L Mao, H Jin, B Hu
Stroke and vascular neurology 5 (3), 2020
|Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative|
GC Fonarow, X Zhao, EE Smith, JL Saver, MJ Reeves, DL Bhatt, Y Xian, ...
Jama 311 (16), 1632-1640, 2014
|Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative|
GC Fonarow, EE Smith, JL Saver, MJ Reeves, AF Hernandez, ...
Stroke 42 (10), 2983-2989, 2011
|Association between stroke center hospitalization for acute ischemic stroke and mortality|
Y Xian, RG Holloway, PS Chan, K Noyes, MN Shah, HH Ting, ...
Jama 305 (4), 373-380, 2011
|Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke|
CB Lin, ED Peterson, EE Smith, JL Saver, L Liang, Y Xian, DWM Olson, ...
Circulation: Cardiovascular quality and outcomes 5 (4), 514-522, 2012
|Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries|
SG Mohile, Y Xian, W Dale, SG Fisher, M Rodin, GR Morrow, A Neugut, ...
Journal of the National Cancer Institute 101 (17), 1206-1215, 2009
|The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery risk models: part 2—statistical methods and results|
SM O’Brien, L Feng, X He, Y Xian, JP Jacobs, V Badhwar, PA Kurlansky, ...
The Annals of thoracic surgery 105 (5), 1419-1428, 2018
|Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator|
Y Xian, L Liang, EE Smith, LH Schwamm, MJ Reeves, DWM Olson, ...
Jama 307 (24), 2600-2608, 2012
|Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With the Guidelines-Stroke|
OJ Ekundayo, JL Saver, GC Fonarow, LH Schwamm, Y Xian, X Zhao, ...
Circulation: Cardiovascular Quality and Outcomes 6 (3), 262-269, 2013
|Association of intracerebral hemorrhage among patients taking non–vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality|
T Inohara, Y Xian, L Liang, RA Matsouaka, JL Saver, EE Smith, ...
Jama 319 (5), 463-473, 2018
|Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation|
Y Xian, EC O’Brien, L Liang, H Xu, LH Schwamm, GC Fonarow, DL Bhatt, ...
Jama 317 (10), 1057-1067, 2017
|Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular …|
S Subherwal, ED Peterson, D Dai, L Thomas, JC Messenger, Y Xian, ...
Journal of the American College of Cardiology 59 (21), 1861-1869, 2012
|Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit|
Y Xian, GC Fonarow, MJ Reeves, LE Webb, J Blevins, VS Demyanenko, ...
American heart journal 163 (3), 392-398. e1, 2012
|A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial|
D Vinereanu, RD Lopes, MC Bahit, D Xavier, J Jiang, HR Al-Khalidi, W He, ...
The Lancet 390 (10104), 1737-1746, 2017
|The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times|
EL Fosbol, CB Granger, JG Jollis, L Monk, L Lin, BL Lytle, Y Xian, ...
Circulation 127 (5), 604-612, 2013
|Association between time to treatment with endovascular reperfusion therapy and outcomes in patients with acute ischemic stroke treated in clinical practice|
R Jahan, JL Saver, LH Schwamm, GC Fonarow, L Liang, RA Matsouaka, ...
Jama 322 (3), 252-263, 2019
|Use of strategies to improve door-to-needle times with tissue-type plasminogen activator in acute ischemic stroke in clinical practice: findings from target: stroke|
Y Xian, H Xu, B Lytle, J Blevins, ED Peterson, AF Hernandez, EE Smith, ...
Circulation: Cardiovascular Quality and Outcomes 10 (1), e003227, 2017
|Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database|
RE Harskamp, JM Brennan, Y Xian, ME Halkos, JD Puskas, VH Thourani, ...
Circulation 130 (11), 872-879, 2014
|Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke|
Y Xian, EE Smith, X Zhao, ED Peterson, DWM Olson, AF Hernandez, ...
Stroke 45 (5), 1387-1395, 2014
|Delays in door-to-needle times and their impact on treatment time and outcomes in get with the guidelines-stroke|
N Kamal, S Sheng, Y Xian, R Matsouaka, MD Hill, DL Bhatt, JL Saver, ...
Stroke 48 (4), 946-954, 2017